Literature DB >> 27502906

Heart Failure With Preserved Ejection Fraction: A Kidney Disorder?

James C Fang1.   

Abstract

Entities:  

Keywords:  heart failure; hypertension; kidney; renal insufficiency

Mesh：

Year:  2016        PMID： 27502906     DOI： 10.1161/CIRCULATIONAHA.116.022249

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  13 in total

1.  Characterization of the Progression From Ambulatory to Hospitalized Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Masaru Obokata; Aaron D Jones; Gregory D Lewis; Sanjiv J Shah; Omar F Abouezzedine; Marat Fudim; Brooke Alhanti; Lynne W Stevenson; Margaret M Redfield; Barry A Borlaug
Journal:  J Card Fail       Date:  2020-08-19       Impact factor: 5.712

Review 2.  Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine.

Authors:  Vincenzo B Polsinelli; Sanjiv J Shah
Journal:  Expert Opin Pharmacother       Date:  2017-02-17       Impact factor: 3.889

Review 3.  Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin.

Authors:  Alberto Aimo; Michele Senni; Andrea Barison; Giorgia Panichella; Claudio Passino; Antoni Bayes-Genis; Michele Emdin
Journal:  Heart Fail Rev       Date:  2022-04-29       Impact factor: 4.654

Review 4.  Is heart failure with preserved ejection fraction a 'dementia' of the heart?

Authors:  Giacomo Tini; Antonio Cannatà; Marco Canepa; Pier Giorgio Masci; Matteo Pardini; Mauro Giacca; Gianfranco Sinagra; Niccolò Marchionni; Federica Del Monte; James E Udelson; Iacopo Olivotto
Journal:  Heart Fail Rev       Date:  2021-04-27       Impact factor: 4.214

5.  Biochemical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors by Cardiovascular Risk Profile and Volume Status in a Real-World Diabetic Population.

Authors:  Mauro Gitto; Alexios S Kotinas; Riccardo Terzi; Angelo Oliva; Jorgele Zagoreo; Bernhard Reimers; Giulio G Stefanini; Marco Mirani; Giuseppe Favacchio; Gianluigi Condorelli; Cristina Panico
Journal:  J Cardiovasc Pharmacol       Date:  2022-07-01       Impact factor: 3.271

Review 6.  Approach and Management of Hypertension After Kidney Transplantation.

Authors:  Ekamol Tantisattamo; Miklos Z Molnar; Bing T Ho; Uttam G Reddy; Donald C Dafoe; Hirohito Ichii; Antoney J Ferrey; Ramy M Hanna; Kamyar Kalantar-Zadeh; Alpesh Amin
Journal:  Front Med (Lausanne)       Date:  2020-06-16

Review 7.  The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.

Authors:  William G Herrington; David Preiss; Richard Haynes; Maximilian von Eynatten; Natalie Staplin; Sibylle J Hauske; Jyothis T George; Jennifer B Green; Martin J Landray; Colin Baigent; Christoph Wanner
Journal:  Clin Kidney J       Date:  2018-10-25

8.  Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.

Authors:  Di Chang; Ting-Ting Xu; Shi-Jun Zhang; Yu Cai; Shu-Dan Min; Zhen Zhao; Chun-Qiang Lu; Yuan-Cheng Wang; Shenghong Ju
Journal:  Exp Biol Med (Maywood)       Date:  2021-08-03

9.  Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".

Authors:  Maria Valero-Muñoz; Warren Backman; Flora Sam
Journal:  JACC Basic Transl Sci       Date:  2017-12-25

10.  Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction.

Authors:  Clotilde Roy; Alisson Slimani; Christophe de Meester; Mihaela Amzulescu; Agnes Pasquet; David Vancraeynest; Christophe Beauloye; Jean-Louis Vanoverschelde; Bernhard L Gerber; Anne-Catherine Pouleur
Journal:  J Cardiovasc Magn Reson       Date:  2018-08-08       Impact factor: 5.364
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.